Understand the source comparison
Pulsatile vs Surge-Mode Kisspeptin Secretion
Kisspeptin neurons in the arcuate nucleus generate pulsatile GnRH secretion. The baseline pattern that maintains tonic LH and FSH levels. These neurons express neurokinin B (NKB) and dynorphin in addition to kisspeptin, forming the so-called KNDy neuron popula
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Kisspeptin neurons in the arcuate nucleus generate pulsatile GnRH secretion. The baseline pattern that maintains tonic LH and FSH levels. These neurons express neurokinin B (NKB) and dynorphin in addition to kisspeptin, forming the so-called KNDy neuron population. NKB acts as an autocrine stimulator: it binds NK3 receptors on the same neuron, triggering synchronized bursts of kisspeptin release across the KNDy neuron network. Dynorphin acts as an autocrine inhibitor: it binds kappa-opioid receptors, terminating the kisspeptin burst and initiating the refractory period before the next pulse. This push-pull system generates the 60–120 minute GnRH pulse intervals observed in humans.
- The AVPV kisspeptin neuron population operates differently. These neurons lack NKB and dynorphin co-expression and respond to sustained high estradiol levels with a massive increase in Kiss1 gene transcription. The mechanism underlying the preovulatory LH surge. In females, rising estradiol during the late follicular phase switches from negative to positive feedback at a threshold concentration (approximately 200 pg/mL sustained for 36–48 hours). This triggers AVPV kisspeptin neurons to release kisspeptin in a continuous, high-amplitude pattern lasting 12–24 hours, driving the GnRH surge that produces the mid-cycle LH surge (10–20× baseline levels) required for ovulation. Males lack this surge capacity because AVPV kisspeptin neurons do not develop estradiol-induced positive feedback. Testosterone and its aromatized metabolite estradiol suppress AVPV kisspeptin activity in males.
- This dual-mode kisspeptin secretion pattern explains several reproductive physiology phenomena. Polycystic ovary syndrome (PCOS) is associated with elevated LH-to-FSH ratios. Consistent with increased GnRH pulse frequency. Studies in PCOS patients show increased arcuate kisspeptin neuron activity and reduced sensitivity to progesterone-mediated pulse frequency slowing. Hypothalamic amenorrhea. Common in athletes and individuals with low body fat. Is associated with suppressed kisspeptin neuron activity and low-frequency GnRH pulses, resulting in low LH and FSH and anovulation. Exogenous kisspeptin administration in hypothalamic amenorrhea restores LH pulsatility within hours, demonstrating that the defect is at the kisspeptin level rather than the pituitary.
- Kisspeptin's role in metabolic-reproductive integration is increasingly recognized. Leptin, the adipocyte-derived hormone signaling energy sufficiency, stimulates arcuate kisspeptin neurons. Ghrelin, the hunger hormone signaling energy deficit, suppresses them. This is why caloric restriction, low body fat, and negative energy balance all suppress kisspeptin LH/FSH release. The mechanism linking metabolic status to fertility. Research in animal models shows that direct leptin administration to kisspeptin neurons restores LH pulsatility in food-restricted animals, bypassing the need for weight restoration.
- The clinical implication: kisspeptin represents a metabolic checkpoint for reproduction. The system prioritizes survival over reproduction. If energy availability is insufficient, kisspeptin neurons reduce activity, GnRH pulses slow, and LH/FSH secretion declines. This is adaptive in evolutionary terms but problematic in modern contexts where intentional caloric restriction or exercise-induced energy deficits suppress fertility despite adequate overall health. Kisspeptin administration in these contexts can "override" the metabolic brake, restoring reproductive axis function without requiring weight gain or reduced exercise. A strategy under investigation in clinical trials for functional hypothalamic amenorrhea. Researchers exploring these pathways often turn to sources like Real Peptides for consistent, high-purity research tools that enable precise mechanistic studies.